ESR1 and breast cancer: Previously, we showed that estrogen receptor and FOXA1, which are known to be activated in estrogen receptor-positive breast cancer subtypes (e.g. luminal A, luminal B), are not expressed in the basal subtype, but FOX and MYB motifs are enriched at enhancers in basal-like breast cancer cells [49].